Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
AMPICILLIN TRIHYDRATE
Fort Dodge Animal Health Limited
QJ01CA04
150 Mg/Ml
Suspension for Injection
Antibacterial
Bovine
1997-10-01
IRISH MEDICINES BOARD ACT 1995 ANIMAL REMEDIES REGULATIONS, 2005 (S.I. NO. 734 OF 2005) VPA: 10861/018/001 Case No: 7001703 The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies Regulations (S.I. No. 734 of 2005) hereby grants to: FORT DODGE ANIMAL HEALTH FLANDERS ROAD, HEDGE END, SOUTHAMPTON SO30 4QH, UNITED KINGDOM an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the Veterinary Medicinal Product: DUPHAMOX LA 50ML The particulars of which are set out in Part 1 and Part 2 of the said Schedule. The authorisation is also subject to any special conditions as may be specified in the said Schedule. Signed on behalf of the Irish Medicines Board this ________________ A person authorised in that behalf by the said Board. (NOTE: This authorisation replaces any previous authorisation in respect of this product which is now null and void.) IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 10/10/2006_ _CRN 7001703_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Duphamox LA, 50ml 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active Substance Amoxicillin Trihydrate 150 mg Excipients Butylated hydroxytoluene 0.08 mg Butylated hydroxyanisole 0.08 mg (as antioxidants). For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Suspension for injection. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, sheep, pigs, dogs, cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES _In vitro _amoxicillin is effective against a wide range of Gram-positive and Gram-negative bacteria which include: _Bacillus anthracis, Baci Read the complete document